We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$494B
AUM Growth
-$24.5B
Cap. Flow
-$42.4B
Cap. Flow %
-8.58%
Top 10 Hldgs %
29.31%
Holding
15,899
New
1,435
Increased
5,761
Reduced
6,731
Closed
1,760

Sector Composition

Rank Sector Weight
1 Technology 3.37%
2 Healthcare 3.33%
3 Consumer Discretionary 2.43%
4 Financials 2.27%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNOV icon
13001
CALL
MediciNova
MNOV
$66M
$10.4K ﹤0.01%
7,200
-5,300
-42% -$7.42K
OSBC icon
13002
PUT
Old Second Bancorp
OSBC
$1.29B
$10.4K ﹤0.01%
700
+600
+600% +$8.44K
NVRI icon
13003
PUT
Enviri
NVRI
$620M
$10.4K ﹤0.01%
1,200
-500
-29% -$4.17K
FHTX icon
13004
PUT
Foghorn Therapeutics
FHTX
$360M
$10.3K ﹤0.01%
1,800
+400
+29% +$2.38K
PLXS icon
13005
PUT
Plexus
PLXS
$7.23B
$10.3K ﹤0.01%
100
-1,600
-94% -$165K
DGS icon
13006
CALL
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.77B
$10.3K ﹤0.01%
200
+100
+100% +$5.15K
SPGP icon
13007
PUT
Invesco S&P 500 GARP ETF
SPGP
$2.32B
$10.3K ﹤0.01%
100
-800
-89% -$82.4K
IGIB icon
13008
PUT
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$10.3K ﹤0.01%
+200
New +$10.2K
INFU icon
13009
CALL
InfuSystem Holdings
INFU
$249M
$10.2K ﹤0.01%
1,500
-10,100
-87% -$74.2K
TRS icon
13010
CALL
TriMas Corp
TRS
$1.44B
$10.2K ﹤0.01%
+400
New +$10.5K
IGTAW
13011
DELISTED
Inception Growth Acquisition Limited Warrants
IGTAW
$10.2K ﹤0.01%
+64,835
New +$6K
PPBT
13012
Purple Biotech
PPBT
$2.33M
$10.2K ﹤0.01%
123
-167
-58% -$19.4K
FULT icon
13013
PUT
Fulton Financial
FULT
$4.64B
$10.2K ﹤0.01%
600
-4,900
-89% -$79.5K
FATE icon
13014
CALL
Fate Therapeutics
FATE
$326M
$10.2K ﹤0.01%
3,100
-10,400
-77% -$45.5K
GTE icon
13015
Gran Tierra Energy
GTE
$317M
$10.2K ﹤0.01%
1,051
-92,651
-99% -$827K
INDB icon
13016
CALL
Independent Bank
INDB
$3.97B
$10.1K ﹤0.01%
200
-1,200
-86% -$60K
BCAB icon
13017
PUT
BioAtla
BCAB
$5.74M
$10.1K ﹤0.01%
148
+56
+61% +$6.66K
IVVD icon
13018
Invivyd
IVVD
$218M
$10.1K ﹤0.01%
9,180
+9,172
+114,650% +$20.3K
RAVE icon
13019
CALL
RAVE Restaurant Group
RAVE
$44.6M
$10.1K ﹤0.01%
5,100
-4,600
-47% -$9.1K
HTCO
13020
High-Trend International Group
HTCO
$29M
$10.1K ﹤0.01%
+714
New +$16.2K
AUTL
13021
PUT
Autolus Therapeutics
AUTL
$562M
$10.1K ﹤0.01%
2,900
-4,700
-62% -$20.3K
NNI icon
13022
CALL
Nelnet
NNI
$4.7B
$10.1K ﹤0.01%
100
-3,300
-97% -$328K
LSDI
13023
DELISTED
Lucy Scientific Discovery Inc. Common Stock
LSDI
$10.1K ﹤0.01%
+19,586
New +$18.6K
VTOL icon
13024
PUT
Bristow Group
VTOL
$1.36B
$10.1K ﹤0.01%
300
-800
-73% -$24.8K
SLGL icon
13025
Sol-Gel Technologies
SLGL
$288M
$10K ﹤0.01%
1,117
-3
-0.3% -$25

Similar funds

Citadel Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Citadel Advisors held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Carrier Global worth $140M.

  • Citadel Advisors's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
  • Citadel Advisors added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
  • Citadel Advisors's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
  • Citadel Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
  • Citadel Advisors's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
  • Citadel Advisors opened 1,435 new positions and closed 1,760 in Q2 2024.
  • Citadel Advisors's portfolio value fell 4.7% quarter-over-quarter to $494B.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.